The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just my opinion
Major shareholder on the weekend said:
We think it’s been an absolutely classic overreaction by the market. Personally I’m very relaxed about the whole thing.
Lets have a good week here - reaching 250 would be a fine thing!
from Questor - HOLD
Shareholder now has 800,000 shares
Keith Ashworth-Lord, who holds Scapa in his SDL UK Buffettology fund, told Questor: “The results in May were nothing other than good, but Chae’s retirement was a bolt from the blue. He is regarded as the architect of the firm in its present form and the market thought there were no succession plans.
“Then, when the ConvaTec announcement came, investors put two and two together, came up with five and crucified the share price.”
He added: “Last week a group of shareholders, including us, tried to get him to change his mind and convince the market that he hadn’t resigned over ConvaTec.
We got the result we wanted this week and the shares have recovered to about 195p.” He said the loss of the contract was “material but not the roof falling in”.
“Chae will stay until the problems are solved and that will give Scapa time to sort out the succession,” he added.
“This holding has not been my finest but we are sticking with it. We bought more shares heavily after the fall – about 800,000 at various prices as low as 159p.
We think it’s been an absolutely classic overreaction by the market. Personally I’m very relaxed about the whole thing.”
https://www.hl.co.uk/shares/shares-search-results/s/scapa-group-plc-ordinary-5p
time =17:10:23
price = 205.804
shares BUY 23,172
cost = 47.69k
and
time =16:56:01
price =208.948
shares =20,000 Buy
cost £41.790
To be fair their were also some hefty shares sold
Look at the Annual Report issued this week.
These shares should be back over 300p already.
136 pages of professionally presented reporting,
with realistic appraisals and optimistic projections
for next 12 months and beyond
Just my opinion - DYOR
In my opinion - even with MM games
Look at Friday where SP dragged back down to 205p from 217.50
Even then buys ended up 9 to 7 over sells
Expect us to test 220p PLUS
Not bad up 18% since open on Monday morning. Had been up 25% at one point this afternoon. Fall from £3+ has obviously been overdone. Still has a ways to go yet even after all the positive news the company has released this past week.
Just selling into the weekend, normal behavior. I'd rather hold in case another rns first thing Monday morning and miss the party.
Cheap as Chips
IMHO - DYOR
quite a lot of sells now - is panic selling?
Wouldn't we all ;-)
Expect lots of stop-loss-orders triggered
as a result MM can potentially balance
position
If I had more spare cash I would buy more @ 106.50
Since then SP has fallen down to 210p but still buys outstrip sells
currently 360k sold
476k bought
Expect rise back to high 217.50 or near that - before close
Another director buy at the 200p price is very positive. Great to have so much confidence from within the company. I think it's just a matter of time before we get news on either another contract or a resolution with Convatec. I'd say Monday morning at the earliest, so still time to avail of the low sp. Onwards and upwards.
So just bought MORE @ 211.28p
Can never resist a BARGAIN - at the price - my opinion
Should not fall too far - but great opportunity to buy more @ slightly lower SP
214.8-216.0
IMHO - DYOR
My projection yesterday of 220p today looks on target
Hit 217.50p a few moments ago
Buya over Sells 31 to 8
Director buys
Pierre Guyot bought 15,000
He now holds 30,000
208.18-209.125
STILL loads to come
BUYS way over sells today
202.7-203.8
graph pointing upwards at a 45 degree angle - very encouraging
Good point halfpenny cheers. I was surprised to see sells from a previous day reported as not seen before.
https://www.hl.co.uk/shares/shares-search-results/s/scapa-group-plc-ordinary-5p
Signal Update
Our system’s recommendation today is to STAY LONG. The previous BUY signal was issued on 12/06/2019, 1 day ago, when the stock price was 184.48. Since then SCPA.L has risen by +7.87%.
Market Outlook
The market is not rosy but our bullish bet is still valid. There is not a definite sign to disturb your comfort. - - - -
https://www.britishbulls.com/m/SignalPage.aspx?lang=en&Ticker=SCPA.L
Many trades posted after hours are dated yesterday, many are from earlier in the day as evident from the price and some will inevitably be UT trades. No worries here.